| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.038 | 0.5 |